# FoldRX Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/foldrx-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Total disclosed funding: $88M
- Latest round: Series C (Jun 15, 2010)
- Investors on record: 8

## About

Founded in 2003 and based in the US, FoldRX Pharmaceuticals, Inc. operates as a pharmaceutical company the engages in the development and research of drugs.

## Funding rounds

- Series C, Jun 15, 2010, $29M — Alta Partners, HealthCare Ventures, Morgenthaler Ventures, TPG, Novartis Venture Fund, Novo Holdings, F-Prime Capital
- Series B, May 30, 2006, $43M — Alta Partners, HealthCare Ventures, Novartis Venture Fund, F-Prime Capital, TPG Biotech
- Series A, Dec 13, 2004, $16M — HealthCare Ventures, F-Prime Capital

## Investors

- HealthCare Ventures — Series A, Series B, Series C
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B, Series C
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series B, Series C
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series B
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series C
- TPG (https://capitalatlas.ai/funds/tpg) — Series C
- Novo Holdings — Series C